Qsemble Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,860
Closed -$540K 564
2026
Q1
$540K Buy
2,860
+560
+24% +$118K 0.04% 345
2025
Q4
$457K Sell
2,300
-9,454
-80% -$1.91M 0.04% 382
2025
Q3
$2.39M Buy
+11,754
New +$2.09M 0.23% 139
2024
Q4
Sell
-1,534
Closed -$255K 530
2024
Q3
$255K Sell
1,534
-7,428
-83% -$1.12M 0.05% 328
2024
Q2
$1.19M Buy
8,962
+1,886
+27% +$227K 0.23% 150
2024
Q1
$744K Buy
7,076
+2,797
+65% +$251K 0.16% 214
2023
Q4
$323K Buy
4,279
+879
+26% +$55.7K 0.08% 287
2023
Q3
$224K Sell
3,400
-3,300
-49% -$247K 0.04% 308
2023
Q2
$545K Buy
+6,700
New +$477K 0.39% 103

Other funds holding THC

Qsemble Capital Management's THC Position: Q2 2026 in Review

Qsemble Capital Management sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 2,860 shares — an estimated $540K sold.

Qsemble Capital Management first reported a position in THC in Q2 2023 and held it in 9 quarters. The position peaked at $2.39M in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Qsemble Capital Management reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Qsemble Capital Management sold 2,860 Tenet Healthcare shares in Q2 2026, an estimated $540K.
  • Qsemble Capital Management first reported a position in Tenet Healthcare in Q2 2023 and held it in 9 quarters.
  • Qsemble Capital Management's Tenet Healthcare position peaked at $2.39M in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Qsemble Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.